BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1200 related articles for article (PubMed ID: 19301169)

  • 1. Selection of CD271(+) cells and human AB serum allows a large expansion of mesenchymal stromal cells from human bone marrow.
    Poloni A; Maurizi G; Rosini V; Mondini E; Mancini S; Discepoli G; Biasio S; Battaglini G; Felicetti S; Berardinelli E; Serrani F; Leoni P
    Cytotherapy; 2009; 11(2):153-62. PubMed ID: 19301169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow.
    Bieback K; Hecker A; Kocaömer A; Lannert H; Schallmoser K; Strunk D; Klüter H
    Stem Cells; 2009 Sep; 27(9):2331-41. PubMed ID: 19544413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media.
    Turnovcova K; Ruzickova K; Vanecek V; Sykova E; Jendelova P
    Cytotherapy; 2009; 11(7):874-85. PubMed ID: 19903100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.
    Stute N; Holtz K; Bubenheim M; Lange C; Blake F; Zander AR
    Exp Hematol; 2004 Dec; 32(12):1212-25. PubMed ID: 15588946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.
    Müller I; Kordowich S; Holzwarth C; Spano C; Isensee G; Staiber A; Viebahn S; Gieseke F; Langer H; Gawaz MP; Horwitz EM; Conte P; Handgretinger R; Dominici M
    Cytotherapy; 2006; 8(5):437-44. PubMed ID: 17050248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
    Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
    Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of BM mesenchymal stem cells by plastic adhesion or negative selection: phenotype, proliferation kinetics and differentiation potential.
    Tondreau T; Lagneaux L; Dejeneffe M; Delforge A; Massy M; Mortier C; Bron D
    Cytotherapy; 2004; 6(4):372-9. PubMed ID: 16146890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
    Lange C; Cakiroglu F; Spiess AN; Cappallo-Obermann H; Dierlamm J; Zander AR
    J Cell Physiol; 2007 Oct; 213(1):18-26. PubMed ID: 17458897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta.
    Poloni A; Rosini V; Mondini E; Maurizi G; Mancini S; Discepoli G; Biasio S; Battaglini G; Berardinelli E; Serrani F; Leoni P
    Cytotherapy; 2008; 10(7):690-7. PubMed ID: 18985476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat marrow-derived mesenchymal stem cells developed in a medium supplemented with the autologous versus bovine serum.
    Eslaminejad MB; Rouhi L; Arabnajafi M; Baharvand H
    Cell Biol Int; 2009 May; 33(5):607-16. PubMed ID: 19286467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic changes of adult porcine mesenchymal stem cells induced by prolonged passaging in culture.
    Vacanti V; Kong E; Suzuki G; Sato K; Canty JM; Lee T
    J Cell Physiol; 2005 Nov; 205(2):194-201. PubMed ID: 15880640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells.
    Shetty P; Bharucha K; Tanavde V
    Cell Biol Int; 2007 Mar; 31(3):293-8. PubMed ID: 17208468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone-forming capacity of mesenchymal stromal cells when cultured in the presence of human platelet lysate as substitute for fetal bovine serum.
    Prins HJ; Rozemuller H; Vonk-Griffioen S; Verweij VG; Dhert WJ; Slaper-Cortenbach IC; Martens AC
    Tissue Eng Part A; 2009 Dec; 15(12):3741-51. PubMed ID: 19519274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment for STRO-1 expression enhances the cardiovascular paracrine activity of human bone marrow-derived mesenchymal cell populations.
    Psaltis PJ; Paton S; See F; Arthur A; Martin S; Itescu S; Worthley SG; Gronthos S; Zannettino AC
    J Cell Physiol; 2010 May; 223(2):530-40. PubMed ID: 20162565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use.
    Haack-Sorensen M; Bindslev L; Mortensen S; Friis T; Kastrup J
    Cytotherapy; 2007; 9(4):328-37. PubMed ID: 17573608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Stro-1(+) human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system.
    Gonçalves R; Lobato da Silva C; Cabral JM; Zanjani ED; Almeida-Porada G
    Exp Hematol; 2006 Oct; 34(10):1353-9. PubMed ID: 16982328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood.
    Manca MF; Zwart I; Beo J; Palasingham R; Jen LS; Navarrete R; Girdlestone J; Navarrete CV
    Cytotherapy; 2008; 10(1):54-68. PubMed ID: 18202975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression.
    Montesinos JJ; Flores-Figueroa E; Castillo-Medina S; Flores-Guzmán P; Hernández-Estévez E; Fajardo-Orduña G; Orozco S; Mayani H
    Cytotherapy; 2009; 11(2):163-76. PubMed ID: 19152152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Thy-1 (CD90) antigen expression on mesenchymal stromal cells from hematologic malignancies is induced by in vitro angiogenic stimuli and is associated with peculiar functional and phenotypic characteristics.
    Campioni D; Lanza F; Moretti S; Ferrari L; Cuneo A
    Cytotherapy; 2008; 10(1):69-82. PubMed ID: 18202976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.